NCT00643539 - Multicenter, Open, Randomized Comparative Trial To Compare The Efficacy Of Azithromycin Versus Amoxicillin In Children With Strep Throat | Biotech Hunter

Enrollment

360

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

July 31, 2003

Conditions

Tonsillitis

Interventions

DRUG

Zithromax

azithromycin (Zithromax) pediatric suspension formulation (200 mg/5 ml) administered as an oral suspension at a dose of 20 mg/kg once a day (maximal dose 500 mg/day) for 3 consecutive days

DRUG

Clamoxyl

Amoxicillin (Clamoxyl) pediatric formulation (500 mg/5 ml) administered as an oral suspension at a dose of 25 mg/kg twice daily (maximal dose 2 g/day) for 6 consecutive days

Trial Locations (45)

13006

Pfizer Investigational Site, Marseille

13013

Pfizer Investigational Site, Marseille

13014

Pfizer Investigational Site, Marseille

13300

Pfizer Investigational Site, Salon-de-Provence

19100

Pfizer Investigational Site, Brivé

21000

Pfizer Investigational Site, Dijon

21490

Pfizer Investigational Site, Varois-et-Chaignot

29200

Pfizer Investigational Site, Brest

32000

Pfizer Investigational Site, Auch

33170

Pfizer Investigational Site, Draguignan

33370

Pfizer Investigational Site, Tresses

37000

Pfizer Investigational Site, Tours

44150

Pfizer Investigational Site, Ancenis

51000

Pfizer Investigational Site, Châlons-en-Champagne

54270

Pfizer Investigational Site, Essey-lès-Nancy

54500

Pfizer Investigational Site, Vandœuvre-lès-Nancy

57100

Pfizer Investigational Site, Thionville

67100

Pfizer Investigational Site, Strasbourg

67600

Pfizer Investigational Site, Sélestat

69330

Pfizer Investigational Site, Meysieu

69390

Pfizer Investigational Site, Millery

71380

Pfizer Investigational Site, Saint-Marcel